AVDL Financial Statements

Balance sheet, income statement, cash flow, and dividends for Avadel Pharmaceuticals Plc (AVDL).


$1.01B Market Cap.

As of 03/03/2025 5:00 PM ET (MRY) • Disclaimer

AVDL Market Cap. (MRY)


AVDL Shares Outstanding (MRY)


AVDL Assets (MRY)


Total Assets

$164.24M

Total Liabilities

$90.39M

Total Investments

$22.41M

AVDL Income (MRY)


Revenue

$169.12M

Net Income

-$48.83M

Operating Expense

$196.24M

AVDL Cash Flow (MRY)


CF Operations

-$46.91M

CF Investing

$51.78M

CF Financing

$15.97M

AVDL Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AVDL Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$164,236,000 (-0.28%)

$164,698,000 (24.03%)

$132,785,000 (-46.30%)

$247,265,000 (-20.66%)

Assets Current

$134,208,000 (0.00%)

$134,202,000 (33.08%)

$100,843,000 (-47.61%)

$192,490,000 (-26.94%)

Assets Non-Current

$30,028,000 (-1.53%)

$30,496,000 (-4.53%)

$31,942,000 (-41.69%)

$54,775,000 (13.68%)

Goodwill & Intangible Assets

$16,836,000 (0.00%)

$16,836,000 (0.00%)

$16,836,000 (0.00%)

$16,836,000 (0.00%)

Shareholders Equity

$73,848,000 (-15.83%)

$87,739,000 (514.94%)

-$21,145,000 (-127.02%)

$78,244,000 (-51.78%)

Property Plant & Equipment Net

$2,155,000 (-32.15%)

$3,176,000 (24.45%)

$2,552,000 (-13.11%)

$2,937,000 (-0.88%)

Cash & Equivalents

$51,371,000 (64.82%)

$31,167,000 (-57.87%)

$73,981,000 (45.90%)

$50,708,000 (-29.30%)

Accumulated Other Comprehensive Income

-$24,580,000 (-6.10%)

-$23,167,000 (12.05%)

-$26,341,000 (-10.03%)

-$23,940,000 (-13.72%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$22,406,000 (-69.70%)

$73,944,000 (228.38%)

$22,518,000 (-78.86%)

$106,513,000 (-28.84%)

Investments Current

$22,406,000 (-69.70%)

$73,944,000 (228.38%)

$22,518,000 (-78.86%)

$106,513,000 (-28.84%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$20,298,000 (95.55%)

$10,380,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$34,097,000 (181.72%)

$12,103,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$7,328,000 (-35.90%)

$11,433,000 (44.90%)

$7,890,000 (2.75%)

$7,679,000 (161.72%)

Accumulated Retained Earnings (Deficit)

-$794,328,000 (-6.55%)

-$745,496,000 (-27.39%)

-$585,220,000 (-30.70%)

-$447,756,000 (-16.55%)

Tax Assets

$0 (0%)

$1,654,000 (-52.47%)

$3,480,000 (-5.13%)

$3,668,000 (-45.83%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$36,953,000 (4.43%)

$35,384,000 (-72.99%)

$131,022,000 (-9.64%)

$145,004,000 (11.09%)

Debt Current

$582,000 (-37.69%)

$934,000 (-97.58%)

$38,628,000 (4192.00%)

$900,000 (89.87%)

Debt Non-Current

$36,371,000 (5.58%)

$34,450,000 (-62.71%)

$92,394,000 (-35.88%)

$144,104,000 (10.81%)

Total Liabilities

$90,388,000 (17.45%)

$76,959,000 (-50.00%)

$153,930,000 (-8.93%)

$169,021,000 (13.16%)

Liabilities Current

$48,834,000 (32.50%)

$36,855,000 (-33.94%)

$55,793,000 (165.68%)

$21,000,000 (38.99%)

Liabilities Non-Current

$41,554,000 (3.62%)

$40,104,000 (-59.13%)

$98,137,000 (-33.70%)

$148,021,000 (10.25%)

AVDL Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$169,117,000 (504.79%)

$27,963,000 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$15,277,000 (1705.79%)

$846,000 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$181,043,000 (19.34%)

$151,705,000 (103.59%)

$74,516,000 (8.79%)

$68,495,000 (111.37%)

Research & Development Expense

$15,196,000 (14.59%)

$13,261,000 (-35.94%)

$20,700,000 (21.02%)

$17,104,000 (-16.33%)

Operating Expenses

$196,239,000 (18.96%)

$164,966,000 (67.37%)

$98,561,000 (15.21%)

$85,546,000 (1048.27%)

Interest Expense

$10,830,000 (9.55%)

$9,886,000 (-19.90%)

$12,342,000 (24.14%)

$9,942,000 (-23.49%)

Income Tax Expense

-$247,000 (50.70%)

-$501,000 (-101.93%)

$26,025,000 (264.55%)

-$15,816,000 (-30.60%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$48,832,000 (69.53%)

-$160,276,000 (-16.59%)

-$137,464,000 (-77.77%)

-$77,329,000 (-1200.30%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$48,832,000 (69.53%)

-$160,276,000 (-16.59%)

-$137,464,000 (-77.77%)

-$77,329,000 (-1200.30%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$48,832,000 (69.53%)

-$160,276,000 (-16.59%)

-$137,464,000 (-77.77%)

-$77,329,000 (-1200.30%)

Weighted Average Shares

$95,141,000 (18.67%)

$80,174,000 (33.41%)

$60,094,000 (2.66%)

$58,535,000 (10.45%)

Weighted Average Shares Diluted

$95,141,000 (18.67%)

$80,174,000 (33.41%)

$60,094,000 (2.66%)

$58,535,000 (6.54%)

Earning Before Interest & Taxes (EBIT)

-$38,249,000 (74.65%)

-$150,891,000 (-52.27%)

-$99,097,000 (-19.10%)

-$83,203,000 (-1151.61%)

Gross Profit

$153,840,000 (467.32%)

$27,117,000 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$42,399,000 (69.24%)

-$137,849,000 (-39.86%)

-$98,561,000 (-15.21%)

-$85,546,000 (-1035.75%)

AVDL Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$51,780,000 (203.37%)

-$50,093,000 (-162.85%)

$79,698,000 (40.00%)

$56,929,000 (181.65%)

Net Cash Flow from Financing

$15,970,000 (-88.20%)

$135,335,000 (830.59%)

$14,543,000 (5429.66%)

$263,000 (-99.85%)

Net Cash Flow from Operations

-$46,907,000 (63.50%)

-$128,511,000 (-82.79%)

-$70,304,000 (9.06%)

-$77,310,000 (-58.64%)

Net Cash Flow / Change in Cash & Cash Equivalents

$20,204,000 (147.19%)

-$42,814,000 (-283.96%)

$23,273,000 (210.75%)

-$21,014,000 (-133.92%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$16,500,000 (-35.29%)

Net Cash Flow - Investment Acquisitions and Disposals

$51,780,000 (203.37%)

-$50,093,000 (-162.29%)

$80,414,000 (98.77%)

$40,455,000 (142.53%)

Capital Expenditure

$0 (0%)

$0 (0%)

-$716,000 (-2653.85%)

-$26,000 (73.47%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$13,022,000 (3.23%)

-$13,457,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$15,970,000 (-89.24%)

$148,357,000 (429.85%)

$28,000,000 (10546.39%)

$263,000 (-99.85%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$639,000 (-240.44%)

$455,000 (168.52%)

-$664,000 (25.89%)

-$896,000 (-224.44%)

Share Based Compensation

$20,387,000 (28.94%)

$15,811,000 (125.45%)

$7,013,000 (-20.95%)

$8,872,000 (195.83%)

Depreciation Amortization & Accretion

$2,681,000 (51.81%)

$1,766,000 (18.29%)

$1,493,000 (83.19%)

$815,000 (-51.78%)

AVDL Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

91.00% (-6.19%)

97.00%

-

-

Profit Margin

-28.90% (94.96%)

-573.20%

-

-

EBITDA Margin

-21.00% (96.06%)

-533.30%

-

-

Return on Average Equity (ROAE)

-65.70% (68.95%)

-211.60% (92.95%)

-3002.20% (-4098.88%)

-71.50% (-1501.96%)

Return on Average Assets (ROAA)

-30.10% (66.70%)

-90.40% (-8.13%)

-83.60% (-193.33%)

-28.50% (-1287.50%)

Return on Sales (ROS)

-22.60% (95.81%)

-539.60%

-

-

Return on Invested Capital (ROIC)

-38.30% (72.58%)

-139.70% (-148.13%)

-56.30% (-119.07%)

-25.70% (-1088.46%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-20.61 (-191.90%)

-7.06 (-125.78%)

-3.13 (48.91%)

-6.12 (-111.91%)

Price to Sales Ratio (P/S)

5.91 (-85.39%)

40.48

-

-

Price to Book Ratio (P/B)

13.71 (-5.11%)

14.45 (169.09%)

-20.92 (-445.54%)

6.05 (152.36%)

Debt to Equity Ratio (D/E)

1.22 (39.57%)

0.88 (112.05%)

-7.28 (-437.04%)

2.16 (134.53%)

Earnings Per Share (EPS)

-0.51 (74.50%)

-2 (12.66%)

-2.29 (-73.48%)

-1.32 (-1115.38%)

Sales Per Share (SPS)

1.78 (409.46%)

0.35 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.49 (69.25%)

-1.6 (-35.62%)

-1.18 (10.52%)

-1.32 (-43.43%)

Book Value Per Share (BVPS)

0.78 (-29.07%)

1.09 (410.80%)

-0.35 (-126.33%)

1.34 (-56.34%)

Tangible Assets Book Value Per Share (TABVPS)

1.55 (-16.00%)

1.84 (-4.41%)

1.93 (-51.00%)

3.94 (-29.23%)

Enterprise Value Over EBIT (EV/EBIT)

-27 (-237.50%)

-8 (-60.00%)

-5 (28.57%)

-7 (-112.73%)

Enterprise Value Over EBITDA (EV/EBITDA)

-28.69 (-236.54%)

-8.53 (-60.05%)

-5.33 (21.56%)

-6.79 (-114.98%)

Asset Turnover

1.04 (560.76%)

0.16 (0%)

0 (0%)

0 (0%)

Current Ratio

2.75 (-24.53%)

3.64 (101.49%)

1.81 (-80.29%)

9.17 (-47.43%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$46,907,000 (63.50%)

-$128,511,000 (-80.95%)

-$71,020,000 (8.17%)

-$77,336,000 (-58.37%)

Enterprise Value (EV)

$1,020,555,659 (-19.73%)

$1,271,426,820 (144.56%)

$519,890,721 (-7.08%)

$559,531,311 (28.58%)

Earnings Before Tax (EBT)

-$49,079,000 (69.47%)

-$160,777,000 (-44.27%)

-$111,439,000 (-19.64%)

-$93,145,000 (-1732.84%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$35,568,000 (76.15%)

-$149,125,000 (-52.79%)

-$97,604,000 (-18.47%)

-$82,388,000 (-958.03%)

Invested Capital

$84,148,000 (-26.97%)

$115,224,000 (-1.68%)

$117,197,000 (-61.41%)

$303,725,000 (-10.27%)

Working Capital

$85,374,000 (-12.30%)

$97,347,000 (116.09%)

$45,050,000 (-73.73%)

$171,490,000 (-30.95%)

Tangible Asset Value

$147,400,000 (-0.31%)

$147,862,000 (27.52%)

$115,949,000 (-49.68%)

$230,429,000 (-21.84%)

Market Capitalization

$1,012,759,659 (-20.13%)

$1,268,055,820 (186.67%)

$442,335,721 (-6.61%)

$473,650,311 (21.68%)

Average Equity

$74,295,750 (-1.89%)

$75,728,500 (1553.91%)

$4,578,750 (-95.77%)

$108,146,250 (-21.01%)

Average Assets

$161,977,250 (-8.68%)

$177,378,250 (7.89%)

$164,402,000 (-39.50%)

$271,721,500 (-8.54%)

Invested Capital Average

$99,916,500 (-7.46%)

$107,974,000 (-38.65%)

$175,987,750 (-45.72%)

$324,234,250 (7.72%)

Shares

96,361,528 (7.30%)

89,805,653 (45.37%)

61,778,732 (5.39%)

58,620,088 (0.60%)